Partner Content

MM+M podcast with Real Chemistry

Steve Madden, GM and Editor-in-Chief of MM+M and Jim Weiss, Founder and CEO of W2O talk about current vaccination run rates in the US and globally and bold predictions on what a return to normalcy looks like.

MM+M Staff

March 2, 2021

5:18 pm

The Vaccine Confidence Project: How We Get from Shelter-in-place to Herd Immunity

Listen in as two front-line leaders, Steve Madden, GM and Editor-in-Chief of MM+M and Jim Weiss, Founder and CEO of Healthcare Marketing and Communications firm, Real Chemistry, talk about:

The state of the state – current vaccination run rates in the US and globally.

Who is manufacturing what and how much?

Which companies/organizations are doing a great job in building vaccine confidence?

Bold predictions on what a return to normalcy looks like and when it might happen.

From Our Partners

How AI and first-party data is transforming pharma customer engagement

Partner Content

How AI and first-party data is transforming pharma customer engagement

Using technology to improve audience segmentation, targeting and virtual interaction.

The importance of female representation in health

Partner Content

The importance of female representation in health

How to effect change and close the gender gap in healthcare.

The A100 Playbook Podcast | Real Chemistry: Visualizing the future: Art, science and AI innovation

Partner Content

The A100 Playbook Podcast | Real Chemistry: Visualizing the future: Art, science and AI innovation

Listen to Jack O’Brien of MM+M and Brandon Pletsch, president of scientific visualization at Real Chemistry, as they delve into the dynamic intersection of art, science and AI innovation in the field of scientific visualization.

Garbage in, garbage out — How health marketers can ensure the right information reaches patients and HCPs

Partner Content

Garbage in, garbage out — How health marketers can ensure the right information reaches patients and HCPs

This session with Justin Freid, chief marketing and innovation officer of CMI Media Group, and Daniel Nadler, founder of Open Evidence, will enlighten health brands to the possibilities of AI.